Dade, The joint venture with SFIO must be something you have missed. SFIO moved their headquarters to SoCal in June just so they could operate in the California MedMJ world and if prop 19 passes. I spoke to the IR at SFIO, Kim, and he explained that they still could profit if prop 19 doesn't pass based on selling the devices. How they work that out I am not sure, but it is a 50% revenue share and I would guess that is something they have as plan B.
Make no mistake, if prop 19 doesn't pass it is not the best news for that joint venture. However, they will be using this technology as their delivery system to get through FDA or foreign FDA like trials. I would guess they will have alternative delivery for ingestion, but as of now this is what sets them apart from GW.
I wish someone could physically go to Rockbrook and advise if they are using CBIS smokeless, tincture, or bud as the products they are selling.
News 
Market Data 
Discover 
